Showing results (1431-1440 of 3,637) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|October 12, 2014
Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgeryN Biglia, R Ponzone, V E Bounous, et al.Breast (Edinburgh, Scotland)|October 15, 2014
Current status of hormone therapy in patients with hormone receptor positive (HR+) advanced breast cancerElsa Dalmau, Alejandra Armengol-Alonso, Montserrat Muñoz, et al.Breast (Edinburgh, Scotland)|September 18, 2014
Re-resection rates and risk characteristics following breast conserving surgery for breast cancer and carcinoma in situ: A single-centre study of 1575 consecutive casesC G Kryh, C A Pietersen, H B Rahr, et al.Breast (Edinburgh, Scotland)|August 2, 2014
Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled studyL Aerts, M R Christiaens, P Enzlin, et al.Breast (Edinburgh, Scotland)|August 5, 2014
Ovarian function preservation with GnRH agonist in young breast cancer patients: does it impede the effect of adjuvant chemotherapy?Jiyoung Kim, Minkook Kim, Jun Ho Lee, et al.Breast (Edinburgh, Scotland)|July 16, 2014
Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysisH Staley, I McCallum, J BruceBreast (Edinburgh, Scotland)|July 19, 2014
Current and future role of neoadjuvant therapy for breast cancerMichael Untch, Gottfried E Konecny, Stefan Paepke, et al.Breast (Edinburgh, Scotland)|September 3, 2013
A new scarless oncoplastic breast-conserving surgery: modified round block techniqueHisamitsu Zaha, Mai Onomura, Mikiko UnesokoBreast (Edinburgh, Scotland)|August 24, 2013
Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxelB K Linderholm, E Lidbrink, E Tallroth, et al.Breast (Edinburgh, Scotland)|August 24, 2013
Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancerH Hartog, H M Boezen, M M de Jong, et al.Pageof 364